Effects of daclizumab hyp on accumulation of disability exclusive of acute relapse in moderately/severely disabled relapsing-remitting multiple sclerosis patients: Neurophysical composite outcome from the decide study

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: 1a49d8def9c94e484f53ec4f966cc16aa6e9df86
First added on: Feb 07, 2025